Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RTX vs MRNA✓SelectedUSD · MRNARTX vs MRNA performance historyLatest closeAs of-1.86%11/16
Stock and ETF performance explorer

RTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+156.0%
MRNA return
+182.7%
Excess return
-26.7%
Maximum drawdown
-20.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.9%-3.6%+1.8%-1.8%
7D-0.7%-20.0%+19.3%-0.6%
30D+0.5%-1.3%+1.8%+0.5%
3M-12.6%+240.0%-252.6%-13.7%
6M+14.7%+339.0%-324.3%+11.3%
YTD+7.4%+630.0%-622.6%+1.2%
1Y+12.7%+769.1%-756.4%+5.2%
3Y+156.0%+181.2%-25.2%+145.5%
All+156.0%+182.7%-26.7%+145.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling